Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Invested Capital (2016 - 2025)

Dare Bioscience's Invested Capital history spans 11 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 172.18% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, up 172.18%, while the annual FY2025 figure was $4.3 million, 172.18% up from the prior year.
  • Invested Capital reached $4.3 million in Q4 2025 per DARE's latest filing, down from $4.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $38.8 million in Q4 2021 to a low of -$11.0 million in Q1 2024.
  • Average Invested Capital over 5 years is $7.8 million, with a median of $4.3 million recorded in 2021.
  • Peak YoY movement for Invested Capital: surged 25641.13% in 2021, then crashed 501.92% in 2025.
  • A 5-year view of Invested Capital shows it stood at $38.8 million in 2021, then tumbled by 71.33% to $11.1 million in 2022, then plummeted by 145.42% to -$5.0 million in 2023, then fell by 19.03% to -$6.0 million in 2024, then skyrocketed by 172.18% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Invested Capital are $4.3 million (Q4 2025), $4.9 million (Q3 2025), and -$10.7 million (Q2 2025).